Project Number 5R01AG033133-03 Agency/Funding Organization NIA Funding Year 2011 View Full Project Details for PRAZOSIN TREATMENT FOR DISRUPTIVE AGITATION IN ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator PESKIND, ELAINE R. Principal Investigator First Name ELAINE R. Principal Investigator Last Name PESKIND Awardee Organization SEATTLE INST FOR BIOMEDICAL/CLINICAL RES Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-062: Alzheimers Disease Pilot Clinical Trials (R01) FY Overall Cost $476,774 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
